Results 311 to 320 of about 476,894 (337)

Evaluation of pregabalin-induced adverse events related to falls using the FDA adverse event reporting system and Japanese Adverse Drug Event Report databases

Journal of Clinical Pharmacy and Therapeutics, 2018
Pregabalin is used for neuropathic and postherpetic pain and generalized anxiety. The aim of this study was to obtain the onset profiles of adverse events (AE) related to falls (AEFs) such as "somnolence," "dizziness," "loss of consciousness" and "fall" onset and several clinical factor combinations such as age and administered dose, using spontaneous ...
Ririka Mukai, Shiori Hasegawa, Ryogo Umetsu, Satoshi Nakao, Kazuyo Shimada, Hiroaki Uranishi, Mayuko Masuta, Honami Suzuki, Yuri Nishibata, Mitsuhiro Nakamura   +9 more
openaire   +3 more sources

Adverse event reporting: making the system work.

Biomedical instrumentation & technology, 2005
111 Anurse inadvertently connects a blood pressure cuff to an intravenous line, pumping the patient full of air. A portable infusion pump delivers the wrong dose of medication. An arthroscopic irrigation pump shoots fluid with too much pressure, permanently damaging a patient’s knee.
openaire   +3 more sources

Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database

Drug Safety, 2012
Bevacizumab is the first in its class, vascular endothelial growth factor (VEGF) inhibitor that was initially approved by the US FDA in 2004 for the treatment of metastatic colon cancer and other solid tumors. Preapproval clinical trials, particularly for oncology drugs, are limited in their ability to detect certain adverse effects and, therefore, the
Behrooz K. Shamloo, Sheila Weiss Smith, Jennifer L. Malin, Andrew N. Freedman, Pankdeep Chhabra, Arnold L. Potosky   +5 more
openaire   +3 more sources

Novel adverse events of vortioxetine: A disproportionality analysis in USFDA adverse event reporting system database

Asian Journal of Psychiatry, 2017
Signal detection is one of the most advanced and emerging field in pharmacovigilance. It is a modern method of detecting new reaction (which can be desired or undesired) of a drug. It facilitates early adverse drug reaction detection which enables health professionals to identify adverse events that may not have been identified in pre-marketing ...
Hemendra Singh, Eswaran Maheswari, Elsa Beulah, Viswam Subeesh   +3 more
openaire   +3 more sources

Brain and other central nervous system tumor statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Carol Kruchko, Kristin A Waite, Kimberly D Miller   +2 more
exaly  

[Adverse events and adverse event reporting systems].

Der Anaesthesist, 2008
Knowledge about the incidence of errors in anaesthesia and intensive care is only rudimentary but it appears justified to assume that errors occur much more often than we all expect. One reason is most likely the complexity of our work. Errors may alter our patients' health and healing process, imply financial and legal personal and institutional ...
M, Hübler, A, Möllemann, H, Metzler, T, Koch   +3 more
openaire   +1 more source

The Vaccine Adverse Event Reporting System

Journal of Toxicology: Clinical Toxicology, 1998
openaire   +3 more sources

The need for a chiropractic adverse events reporting system in Australia

Medical Journal of Australia, 2014
John E Cunningham, David Hawkes, Joanne Benhamu   +2 more
openaire   +3 more sources

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Radiation therapy‐associated toxicity: Etiology, management, and prevention

Ca-A Cancer Journal for Clinicians, 2021
Kyle Wang
exaly